| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/10/2003 | EP1341814A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/10/2003 | EP1341811A2 Orally ingestible preparation of mistletoe lectins and method |
| 09/10/2003 | EP1341807A2 Interferon-alpha induced gene |
| 09/10/2003 | EP1341800A2 C-glucosyl ether lipids |
| 09/10/2003 | EP1341792A2 Amido ether substituted imidazoquinolines |
| 09/10/2003 | EP1341791A2 Thioether substituted imidazoquinolines |
| 09/10/2003 | EP1341790A2 Sulfonamido ether substituted imidazoquinolines |
| 09/10/2003 | EP1341789A2 Aryl ether substituted imidazoquinolines |
| 09/10/2003 | EP1341778A1 Klainetin and derivatives thereof, method for their production and the use of the same |
| 09/10/2003 | EP1341771A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors |
| 09/10/2003 | EP1341770A1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors |
| 09/10/2003 | EP1341768A1 Therapeutic benzimidazole compounds |
| 09/10/2003 | EP1341767A2 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 09/10/2003 | EP1341765A1 Therapeutic compounds |
| 09/10/2003 | EP1341761A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-$g(g) BINDING AGENTS |
| 09/10/2003 | EP1341760A1 Sulfonylamino substituted 3-(aminomethylide)-2-indolinones as cell proliferation inhibitors |
| 09/10/2003 | EP1341755A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 09/10/2003 | EP1341754A1 Substituted anthranilic acids |
| 09/10/2003 | EP1341745A1 Retiferol derivatives and their use in the treatment of skin diseases or conditions associated with photodamage |
| 09/10/2003 | EP1341551A2 Treatment of posterior capsule opacification |
| 09/10/2003 | EP1341549A2 Combination therapy for estrogen-dependent disorders |
| 09/10/2003 | EP1341546A2 Kyberdrug as autovaccines with immune-regulating effects |
| 09/10/2003 | EP1341540A2 Tyrosine kinase inhibitors |
| 09/10/2003 | EP1341537A2 Pharmaceutically active isoindoline derivatives |
| 09/10/2003 | EP1341497A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same |
| 09/10/2003 | EP1341412A1 Indolocarbazole anticancer agents and methods of using them |
| 09/10/2003 | EP1259513B1 A NOVEL CRYSTALLINE FORM OF N- 4- 2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO 2,3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR |
| 09/10/2003 | EP1194401B1 Diacylhydrazine derivatives |
| 09/10/2003 | EP1169044B1 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence |
| 09/10/2003 | EP1140818B1 Amidomalonamides and their use as inhibitors of matrix metalloproteinase |
| 09/10/2003 | EP1109583B1 Method and device for delivery of therapeutic agents in conjuction with isotope seed placement |
| 09/10/2003 | EP1094813B1 Use of piperine and derivatives thereof for treating skin pigmentation disorders and skin cancer |
| 09/10/2003 | EP1091948B9 Tubulin binding compounds (cobra) |
| 09/10/2003 | EP1023063B1 INDENO[1,2-c], NAPHTHO[1,2-c]- AND BENZO[6,7]CYCLOHEPTA[1,2-c]PYRAZOLE DERIVATIVES |
| 09/10/2003 | EP0984938B1 Cyanoguanidines as cell proliferation inhibitors |
| 09/10/2003 | EP0981377B1 cOMPLEXES OF THE LHRH-ANTAGONIST CETRORELIX WITH POLY-AMINO ACIDS AND METHOD FOR THEIR PRODUCTION |
| 09/10/2003 | EP0939627B1 Pentafluorobenzenesulfonamides and analogs |
| 09/10/2003 | EP0912570B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/10/2003 | EP0912518B1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 09/10/2003 | EP0885237B1 Oligonucleotide analogues |
| 09/10/2003 | EP0873341B1 Epothilone derivatives, preparation and use |
| 09/10/2003 | EP0873139B1 Biotinylated antibodies with reduced net positive charge and toxin, drug or chelate |
| 09/10/2003 | EP0747389B1 3'-substituted nucleoside derivatives |
| 09/10/2003 | EP0737067B1 Treatment of hormone-unresponsive metastatic prostate cancer |
| 09/10/2003 | EP0594732B1 Humanized antibody against cd18 |
| 09/10/2003 | CN1441808A Chemokine receptor modulators, production and use |
| 09/10/2003 | CN1441805A Antitumoral analogue of Et-743 |
| 09/10/2003 | CN1441803A Indoloquinazolinones |
| 09/10/2003 | CN1441789A Piperazinedione compounds |
| 09/10/2003 | CN1441788A Novel arylethene-sulfonamides compounds |
| 09/10/2003 | CN1441787A Modulators of TNF-alpha signaling |
| 09/10/2003 | CN1441779A Proline derivatives and use thereof as drugs |
| 09/10/2003 | CN1441777A Inhibiting angiogenesis and tumor growth |
| 09/10/2003 | CN1441776A Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives |
| 09/10/2003 | CN1441770A Modified forms of pharmacologically active agents and uses therefor |
| 09/10/2003 | CN1441677A Combined use of anti-cytokine antibodies or antagonists and anti-CD2O for treatment of B cell lymphoma |
| 09/10/2003 | CN1441676A Method of treatment using ligand-immunogen conjugates |
| 09/10/2003 | CN1441673A 4,5-dihydro-thiazo-2-ylamine derivatives and their use as NO-synthase inhibitors |
| 09/10/2003 | CN1441671A Fatty acid analogues for treatment of cancer |
| 09/10/2003 | CN1441667A Pharmaceutical compositions |
| 09/10/2003 | CN1440980A Mannosan peptide and its prepn and use |
| 09/10/2003 | CN1440975A Wood oligosaccharide capable of being used as medicine and its prepn process and medicine composite |
| 09/10/2003 | CN1440973A Optical pure analog of camptothecine |
| 09/10/2003 | CN1440972A Optical pure synthetic intermediate of camptothecine and its preparing method |
| 09/10/2003 | CN1440971A Vitronectin receptor antagnist, its preparation and use |
| 09/10/2003 | CN1440816A Improvement for diagnosis and/or therapeutic agnet and its relative improvement |
| 09/10/2003 | CN1440812A Method of strengthening immune response with CD137 conjugated excitomotor |
| 09/10/2003 | CN1440795A Medicine for auxiliary trearment after radiotherapy and chemotherapy of tumor |
| 09/10/2003 | CN1440782A Prepn process and recipe of composite nano emulsion containing coix seed oil and java brucea fruit |
| 09/10/2003 | CN1440779A Chinese medicine decoction for treating lung cancer and its prepn |
| 09/10/2003 | CN1440769A Chinese herbal medicine for treating hemopathy |
| 09/10/2003 | CN1440751A Matrix metal proteinase and tumor necrosis inhibitor |
| 09/10/2003 | CN1440750A Delayed releasing kurarinol prepn |
| 09/10/2003 | CN1440748A Water soluble anticancer medicine taxol composite and its prepn |
| 09/10/2003 | CN1120832C Anti-tumour compound and its prepn. and pharmaceutical use |
| 09/10/2003 | CN1120723C Health-care lucid ganoderma product and its preparing process |
| 09/10/2003 | CN1120708C Medicine prepared from bolostemmatoside B for preventing and curing tumor |
| 09/09/2003 | US6617450 P-glycoproteins and uses thereof |
| 09/09/2003 | US6617440 Isolated polynucleotide that promotes transcription; gene expression inhibition; used for engineering animals with increased lean meat and promoting muscle growth; treating muscular disorders |
| 09/09/2003 | US6617432 Useful as markers in diagnosing, monitoring the stage of malignancy and treating prostate cancer |
| 09/09/2003 | US6617430 Ataxin-2 binding proteins |
| 09/09/2003 | US6617361 Protocol for prevention of Alzheimer's disease involves stimulating implicit memory; psychotherapeutic or psychological supports; stimulating explicit memory; transfers learned behavior into the implicit memory. |
| 09/09/2003 | US6617348 Treating or preventing osteoporosis |
| 09/09/2003 | US6617346 Inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity |
| 09/09/2003 | US6617344 Heterocyclically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising them |
| 09/09/2003 | US6617333 Antineoplastic combinations comprising |
| 09/09/2003 | US6617331 Purine inhibitors of protein kinases, G proteins and polymerases |
| 09/09/2003 | US6617329 Aminoquinazolines and their use as medicaments |
| 09/09/2003 | US6617317 Boronic ester and acid compositions |
| 09/09/2003 | US6617135 Multiple cytokine protein complexes |
| 09/09/2003 | US6617129 Isolated nucleic acid; prostate-specific gene therapy method; diagnosis and treatment of prostate cancer |
| 09/09/2003 | US6617122 Contacting a compound with a polypeptide, in the presence of adenosine triphosphate (ATP) and detecting its binding or hydrolysis of ATP; use in treatment of coronary artery disease |
| 09/09/2003 | US6617110 Cultured cell comprising a nucleic acid sequence, encoding the protein, that hybridizes to a polynucleotide of given sequence; use to determine if drug is cytotoxic; can use as anticarcinogenic agent |
| 09/09/2003 | US6617102 Screening for a bioactive agent capable of interfering with the binding of a protein; use in diagnosis and treatment of cancer |
| 09/09/2003 | US6616925 Combined preparation for the treatment of neoplasic diseases or of infectious diseases |
| 09/09/2003 | US6616591 Radioactive compositions and methods of use thereof |
| 09/09/2003 | CA2263566C Substituted 6,5-hetero-bicyclic derivatives |
| 09/09/2003 | CA2248953C Novel benzofuranone derivatives and process for producing the same |
| 09/09/2003 | CA2244867C Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant |
| 09/09/2003 | CA2130174C 4-oxo-2 thioxoimidazolidine derivatives as inhibitors of blood platelet aggregation |